Read + Share
Ding W, Ye D, Chen H, Lin Y, et al. Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs
ER+/PR-/HER2+ breast cancer subtypes. Breast Cancer 2024 Jan 17. doi: 10.1007/s12282-023-01538.
PMID: 38231460
|
 |
|
Ding W, Ye D, Chen H, Lin Y, et al. Clinicopathological differences and survival benefit in ER+/PR+/HER2+ vs
ER+/PR-/HER2+ breast cancer subtypes. Breast Cancer 2024 Jan 17. doi: 10.1007/s12282-023-01538.
PMID: 38231460
|
|
|
|